Antiviral Approaches, Immunological Interventions and Vaccination for Effective Virus Spread Control and Prevention

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 225

Special Issue Editors


E-Mail Website
Guest Editor
1. Laboratório de Morfologia e Morfogênese Viral, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
2. Programa de Pós-Graduação em Biologia Celular e Molecular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
Interests: antiviral drugs; viral immunology; molecular virology; innate immunity

E-Mail Website
Guest Editor
1. Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Brazil
2. Laboratório de Vírus Respiratórios, Exantemáticas e Emergências Virais, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
Interests: viral immunology; vaccines; antiviral drugs; innate immunity

Special Issue Information

Dear Colleagues,

Viral agents represent one of the main groups of pathogens causing morbidity and mortality in humans. Most of these potential agents cause major epidemics and pandemics, as we have seen recently with SARS-CoV-2. The prevention and control of viral spread are highly desirable. In this sense, we encourage the submission of manuscripts with promising results in the research field of antiviral and vaccines, including but not limited to (1) traditional inactivated or live attenuated vaccines, virus-vectored, subunit, viral-like particle, nucleic acid-based vaccine development; (2) new or repurposed molecules that can act directly against the viruses or modulate molecules of the immune system involved in the pathogenesis of viral pathogens of high clinical relevance.

We look forward to receiving your contribution.

Dr. Milene Dias Miranda
Dr. Cristiana Couto Garcia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine development
  • human virus
  • antiviral drug discovery
  • mechanisms of drug action
  • drug–target interaction
  • virus–targeted antivirals
  • immunological interventions
  • innate immunity factors-targeted antivirals
  • nanoproducts and products with antiviral activity
  • virus–host interaction as therapeutic targets
  • clinical trials
  • preclinical studies

Published Papers

This special issue is now open for submission.
Back to TopTop